A 3-year-old boy from Delhi presents to the pediatric outpatient clinic with a history of recurrent respiratory tract infections and poor weight gain since infancy. On examination, he is tachypneic (respiratory rate 40/min), has a hyperdynamic precordium, and a continuous 'machinery' murmur best heard at the left infraclavicular region. Chest X-ray shows cardiomegaly with pulmonary congestion. Echocardiography confirms a patent ductus arteriosus (PDA) with left-to-right shunt. Which of the following is the most appropriate next step in management?

Explanation

## Patent Ductus Arteriosus (PDA) — Management in a 3-Year-Old ### Clinical Presentation & Pathophysiology This child presents with classic signs of a hemodynamically significant PDA with left-to-right shunt: - **Continuous 'machinery' murmur** — pathognomonic finding due to continuous flow from aorta (high pressure) to pulmonary artery (low pressure) throughout the cardiac cycle - **Hyperdynamic precordium** — increased left ventricular stroke volume - **Pulmonary congestion** — volume overload from left-to-right shunt - **Failure to thrive & recurrent infections** — consequences of chronic pulmonary edema and increased work of breathing **Key Point:** A hemodynamically significant PDA (evidenced by cardiomegaly, pulmonary congestion, and symptoms) in a child beyond infancy requires definitive closure. ### Why Surgical Ligation Is Appropriate Here **High-Yield:** NSAIDs (indomethacin/ibuprofen) are effective for PDA closure **primarily in preterm neonates**, where prostaglandin-mediated ductal patency is the dominant mechanism. By 3 years of age, the ductus has undergone structural remodeling (fibrosis, intimal proliferation), and the smooth muscle is no longer responsive to prostaglandin inhibition. NSAIDs are therefore **not effective** in a 3-year-old child. Per Nelson Textbook of Pediatrics (21st edition) and Park's Pediatric Cardiology for Practitioners: - **Indomethacin/ibuprofen** are indicated for PDA closure in **preterm infants** (typically <34 weeks gestation); their efficacy drops sharply after the neonatal period and is negligible in toddlers/older children. - In **symptomatic children beyond infancy**, the standard of care is **surgical ligation** or **catheter-based device closure** (e.g., Amplatzer duct occluder, coil embolization). - Surgical ligation carries a >95% success rate and is the definitive treatment when catheter-based closure is not immediately available or anatomy is unsuitable. ### Why Other Options Are Incorrect | Option | Reasoning | |---|---| | **A) Prostaglandin E1** | Used to **maintain** ductal patency in ductal-dependent lesions (e.g., TGA, critical AS, pulmonary atresia). Contraindicated here — would worsen the left-to-right shunt. | | **C) Diuretics alone until age 5** | Diuretics are adjunctive therapy for symptom relief (pulmonary congestion) but are NOT definitive treatment. Delaying closure risks Eisenmenger syndrome and irreversible pulmonary hypertension. | | **D) Indomethacin/ibuprofen** | Effective only in preterm neonates. In a 3-year-old, the ductus is structurally mature and unresponsive to prostaglandin inhibition. This is a common exam trap. | ### When to Use Each Approach | Intervention | Indication | Age Group | |---|---|---| | **Indomethacin/Ibuprofen** | Symptomatic PDA, no contraindications | Preterm neonates (<34 weeks) | | **Surgical ligation** | Symptomatic PDA in older infants/children, failed NSAIDs, contraindications to catheter closure | Any age; preferred >6 months | | **Catheter-based closure** | Suitable anatomy, weight >5–6 kg | Infants, children, adults | | **Prostaglandin E1** | Ductal-dependent congenital heart lesions | Neonates awaiting surgery | **Clinical Pearl:** In this 3-year-old with symptomatic, hemodynamically significant PDA, NSAIDs are ineffective due to structural maturation of the ductus. Surgical ligation is the most appropriate next step. Catheter-based closure is an equally valid definitive option but is not listed among the choices. **Warning:** Do not confuse the neonatal/preterm management (NSAIDs first-line) with management in older children (surgical or catheter-based closure is first-line). Age is the critical discriminator on exam questions. *Reference: Nelson Textbook of Pediatrics, 21st ed., Chapter on Congenital Heart Disease; Park's Pediatric Cardiology for Practitioners, 6th ed.*